积极监测与低风险DCIS的治疗:LORD试验中的女性偏好
Renée S J M Schmitz1, Ellen G Engelhardt2, Miranda A Gerritsma3
1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
概括
大多数患有低风险管道癌 in situ (DCIS) 的女性更喜欢主动监测 (AS) 而不是传统治疗 (CT). 这凸显了需要确认AS的安全性,以缓解DCIS病例.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 临床试验 临床试验
背景情况:
- 在位管道癌 (DCIS) 可能是惰的,但往往经历了手术和放射治疗的过度治疗.
- 该LORD试验通过为患者提供选择来调查低风险DCIS的积极监测 (AS) 的安全性.
- 了解患者的偏好对于定制乳腺癌管理至关重要.
研究的目的:
- 在LORD试验中,描述AS和常规治疗 (CT) 臂之间的参与者分布.
- 确定患者选择AS或CT用于低风险DCIS的动机.
- 评估与患者在试验中的选择相关的因素.
主要方法:
- 在LORD试验中从基线问卷收集的数据.
- 对参与者分布和特征的描述性统计数据.
- 对患者报告的原因进行主题分析,并对相关因素进行多变量逻辑回归.
主要成果:
- 在377名女性中,76%选择AS,24%选择CT.
- 对AS的主要原因是:"治疗不必要" (59%) 和对AS的信任 (39%).
- 对CT的主要原因:担心癌症 (51%) 和感知到的确定性 (29%). 更低的教育程度和共享决策与AS偏好有关.
结论:
- 该LORD试验是第一个为低风险DCIS提供AS和CT之间的选择.
- 大多数女性更喜欢AS,表达对其安全性的信心.
- 患者的偏好强调了建立AS作为低风险DCIS的安全选择的重要性.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K


